ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

ClinicalTrials.gov ID: NCT00087022

Public ClinicalTrials.gov record NCT00087022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 5:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence (ARISER)

Study identification

NCT ID
NCT00087022
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Heidelberg Pharma AG
Industry
Enrollment
864 participants

Conditions and interventions

Conditions

Interventions

  • girentuximab Biological
  • placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Sep 30, 2012
Completion
Sep 30, 2012
Last update posted
Nov 26, 2018

2004 – 2012

United States locations

U.S. sites
39
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Anchorage Alaska 99508
Jonsson Comprehensive Cancer Center at UCLA Los Angeles California 90095-1781
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115
Helen F. Graham Cancer Center at Christiana Hospital Newark Delaware 19718
Atlantic Urological Associates - Daytona Beach Daytona Beach Florida 32114
Mayo Clinic - Jacksonville Jacksonville Florida 32224
Southeastern Research Group Tallahassee Florida 32308
Winship Cancer Institute of Emory University Atlanta Georgia 30322
Augusta Oncology Associates - Walton Way Augusta Georgia 30901
North Idaho Urology - Coeur d'Alene Coeur d'Alene Idaho 83814-2668
Northeast Indiana Urology, PC Fort Wayne Indiana 46804
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1002
Hematology and Oncology Specialists, LLC - Metairie Metairie Louisiana 70006
Regional Urology, LLC Shreveport Louisiana 71106
Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport Louisiana 71130-3932
Werner-Francis Urology Associates, LLC Greenbelt Maryland 20770
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Lahey Clinic Medical Center - Burlington Burlington Massachusetts 01805
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110
Nevada Cancer Institute Las Vegas Nevada 89135
Community Care Physicians, PC at Urological Institute of NENY Albany New York 12209
Roswell Park Cancer Institute Buffalo New York 14263-0001
AccuMed Research Associates Garden City New York 11530
Mount Sinai School of Medicine New York New York 10029
Hudson Valley Urology, PC Poughkeepsie New York 12601
Our Lady of Mercy Medical Center Comprehensive Cancer Center The Bronx New York 10466
Alliance Urology Specialists - Greensboro Greensboro North Carolina 27403
Carolina BioOncology Institute Huntersville North Carolina 28078
University of Cincinnati Cincinnati Ohio 45219
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Riverside Methodist Hospital Cancer Care Columbus Ohio 43214-3998
Urological Associates of Lancaster, Limited Lancaster Pennsylvania 17604
Urology Associates Nashville Tennessee 37209
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838
Mary Crowley Medical Research Center at Sammons Cancer Center Dallas Texas 75246
Urology Associates of South Texas, PA McAllen Texas 78503
Urology San Antonio, PA - Fredericksburg San Antonio Texas 78229
Vermont Cancer Center at University of Vermont Burlington Vermont 05405-0110
CCOP - Virginia Mason Research Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2018 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00087022 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →